Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

被引：0
|
作者：
Dhakchinamoorthi Krishna Kumar
Deepak Gopal Shewade
Marie-Anne Loriot
Philippe Beaune
Jayaraman Balachander
B. V. Sai Chandran
Chandrasekaran Adithan
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Pharmacology
[2] INSERM UMRS 775,University Paris Sorbonne Cité
[3] Assistance Publique des Hôpitaux de Paris,Department of Biochemistry, Georges Pompidou European Hospital
[4] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiology
[5] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiothoracic and Vascular Surgery
来源：
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词：
Warfarin; Genotype; Polymorphisms; Pharmacogenetic algorithm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [41] VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY
    Zambon, C. -F.
    Pelloso, M.
    Pengo, V.
    Fogar, P.
    Moz, S.
    Nante, G.
    Russo, R.
    Tiso, E.
    Padrini, R.
    Nisi, A.
    Basso, D.
    Plebani, M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S669 - S669
  • [42] Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population
    Chowdhury, Zahid Sadek
    Shahjin, Farah
    Akter, Farhana
    Ahmed, Maizbha Uddin
    Islam, Mohammad Safiqul
    Bin Sayeed, Muhammad Shandaat
    Islam, Reazul
    Hasnat, Abul
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (02) : 341 - 346
  • [43] The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population
    Vear, Susan I.
    Ayers, Gregory D.
    Van Driest, Sara L.
    Sidonio, Robert F.
    Stein, Charles Michael
    Ho, Richard H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 832 - 835
  • [44] Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients
    Wakamiya, Takuya
    Hokosaki, Tatsunori
    Tsujimoto, Shin-ichi
    Kadota, Keisuke
    Nakano, Yusuke
    Watanabe, Shigeo
    Iwamoto, Mari
    Yanagimachi, Masakatsu
    Ito, Shuichi
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (04) : 393 - 400
  • [45] Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes
    Kalpana, S. R.
    Bharath, G.
    Jain, Simran
    Moorthy, Nagaraja
    Manjunath, Satvic C.
    Christopher, Rita
    MEDICINE, 2019, 98 (06)
  • [46] Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes
    Teichert, Martina
    Eijgelsheim, Mark
    Uitterlinden, Andre G.
    Buhre, Peter N.
    Hofman, Albert
    De Smet, Peter A. G. M.
    Visser, Loes E.
    Stricker, Bruno H. Ch.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (01): : 26 - 34
  • [47] Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients
    Takuya Wakamiya
    Tatsunori Hokosaki
    Shin-ichi Tsujimoto
    Keisuke Kadota
    Yusuke Nakano
    Shigeo Watanabe
    Mari Iwamoto
    Masakatsu Yanagimachi
    Shuichi Ito
    Molecular Diagnosis & Therapy, 2016, 20 : 393 - 400
  • [48] GENETIC POLYMORPHISMS OF VKORC1, CYP2C9, CYP4F2 IN BAI-, ZANG-CHINESE
    Tao, Ceng Wu
    HEART, 2011, 97
  • [49] Effect of CYP2C9 and VKORC1 genetic polymorphisms on mean daily maintenance dose of acenocoumarol in South Indian patients
    Kumar, Dhakchinamoorthi Krishna
    Madhan, Sivalingam
    Balachander, Jayaramen
    Chandran, B. V. Sai
    Thamijarassy, Bascarne
    Adithan, Chandrasekaran
    THROMBOSIS RESEARCH, 2013, 131 (04) : 363 - 367
  • [50] Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study
    Sridharan, Kannan
    Al Banna, Rashed
    Malalla, Zainab
    Husain, Aysha
    Sater, Mai
    Jassim, Ghufran
    Otoom, Sameer
    PHARMACOLOGICAL REPORTS, 2021, 73 (05) : 1405 - 1417
12345